5,079 Shares in Tempus AI, Inc. (NASDAQ:TEM) Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The firm acquired 5,079 shares of the company's stock, valued at approximately $178,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Kovitz Investment Group Partners LLC purchased a new stake in shares of Tempus AI during the 3rd quarter worth approximately $1,367,000. China Universal Asset Management Co. Ltd. purchased a new stake in shares of Tempus AI during the 4th quarter worth approximately $1,091,000. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Tempus AI by 1,591.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company's stock worth $68,922,000 after purchasing an additional 1,145,698 shares during the last quarter. Captrust Financial Advisors purchased a new stake in shares of Tempus AI during the 3rd quarter worth approximately $2,726,000. Finally, Sigma Planning Corp purchased a new stake in shares of Tempus AI during the 3rd quarter worth approximately $1,323,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Insider Buying and Selling at Tempus AI

In other news, major shareholder Bradley A. Keywell sold 265,000 shares of Tempus AI stock in a transaction on Friday, January 17th. The shares were sold at an average price of $35.10, for a total transaction of $9,301,500.00. Following the completion of the sale, the insider now directly owns 15,218,365 shares of the company's stock, valued at approximately $534,164,611.50. The trade was a 1.71 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Andrew Polovin sold 51,504 shares of Tempus AI stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the sale, the executive vice president now directly owns 246,085 shares of the company's stock, valued at $10,431,543.15. This represents a 17.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 2,401,779 shares of company stock valued at $115,707,361 in the last three months.

Tempus AI Stock Performance

NASDAQ:TEM traded up $5.69 during trading hours on Monday, hitting $89.44. The stock had a trading volume of 25,048,636 shares, compared to its average volume of 12,947,475. The company has a 50 day simple moving average of $47.46 and a two-hundred day simple moving average of $50.72. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $91.45.

Wall Street Analyst Weigh In

TEM has been the subject of several research analyst reports. Bank of America raised their price target on shares of Tempus AI from $52.00 to $54.00 and gave the stock a "neutral" rating in a research note on Friday, December 13th. Piper Sandler reaffirmed a "neutral" rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. William Blair downgraded shares of Tempus AI from an "outperform" rating to a "market perform" rating in a report on Wednesday, February 12th. Guggenheim initiated coverage on shares of Tempus AI in a report on Monday, December 9th. They issued a "buy" rating and a $74.00 price objective for the company. Finally, Loop Capital cut their price objective on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a report on Tuesday, January 14th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat.com, Tempus AI has an average rating of "Moderate Buy" and an average price target of $58.55.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.